Becton, Dickinson and Company (BDX) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$144.76
Price Target
$172.85
Target Range
$159.00 — $202.00
Analyst Rating
Buy
Forward P/E11.6x
Trailing P/E24.8x
Forward PEG0.70
Implied Growth+102.6%
Median Target$168.01
Analyst Spread24.9%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$159
+9.8%
Consensus
$173
+19.4%
Bull Case
$202
+39.5%
Valuation Model TargetsConfidence: 56/100
Bear$61
Base$182
Bull$189
BDX Price Target Analysis
Updated May 7, 2026As of May 7, 2026, Becton, Dickinson and Company (BDX) has a Wall Street consensus price target of $172.85, based on estimates from 33 covering analysts. With the stock currently trading at $144.76, this represents a potential upside of +19.4%. The company has a market capitalization of $52.45B.
Analyst price targets range from a low of $159.00 to a high of $202.00, representing a 25% spread in expectations. The median target of $168.01 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 16 analysts rating the stock as a Buy or Strong Buy,16 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, BDX trades at a trailing P/E of 24.8x and forward P/E of 11.6x. The forward PEG ratio of 0.70 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +102.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $181.64, with bear and bull scenarios of $61.16 and $188.69 respectively. Model confidence stands at 56/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+34.1%
Avg Forward P/E16.6x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 BAXBaxter International Inc. | $8.8B | $16.98 | $19.75 | +16.3% | Hold | 8.9x | 36 |
 BSXBoston Scientific Corporation | $83.2B | $56.00 | $91.33 | +63.1% | Buy | 16.6x | 43 |
 MDTMedtronic plc | $99.5B | $77.60 | $109.50 | +41.1% | Buy | 14.1x | 49 |
 SYKStryker Corporation | $112.0B | $292.33 | $403.69 | +38.1% | Buy | 19.5x | 50 |
 ZBHZimmer Biomet Holdings, Inc. | $16.2B | $82.83 | $97.90 | +18.2% | Hold | 9.8x | 42 |
 EWEdwards Lifesciences Corporation | $48.0B | $83.20 | $96.53 | +16.0% | Buy | 27.7x | 48 |
 ABTAbbott Laboratories | $150.0B | $86.25 | $128.71 | +49.2% | Buy | 15.7x | 41 |
 DHRDanaher Corporation | $123.8B | $174.92 | $247.00 | +41.2% | Buy | 20.7x | 42 |
 TMOThermo Fisher Scientific Inc. | $175.8B | $472.95 | $654.67 | +38.4% | Buy | 19.0x | 42 |
 HSICHenry Schein, Inc. | $8.3B | $72.44 | $86.43 | +19.3% | Hold | 13.6x | 32 |
Upside Potential Comparison
BSXABTDHRMDTTMOSYKHSICZBHFull BDX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See BDX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BDX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BDX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBDX — Frequently Asked Questions
Quick answers to the most common questions about buying BDX stock.
What is the BDX stock price target for 2026?
Becton, Dickinson and Company (BDX) has a consensus 12-month price target of $172.85, implying 19.4% upside from $144.76. The 33 analysts covering BDX see moderate appreciation potential.
Is BDX a buy, sell, or hold?
BDX has a consensus rating of "Buy" based on 33 Wall Street analysts. The rating breakdown is mixed, with 16 Hold ratings making up the largest segment. The consensus 12-month price target of $172.85 implies 19.4% upside from current levels.
Is BDX stock overvalued or undervalued?
With a forward P/E of 11.5912x, BDX trades at a relatively low valuation. The consensus target of $172.85 implies 19.4% appreciation, suggesting meaningful undervaluation.
How high can BDX stock go?
The most bullish Wall Street analyst has a price target of $202 for BDX, while the most conservative target is $159. The consensus of $172.85 represents the median expectation. Our quantitative valuation model projects a bull case target of $189 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover BDX stock?
BDX is heavily covered by Wall Street, with 33 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 16 have Buy ratings, 16 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the BDX stock forecast?
The 12-month BDX stock forecast based on 33 Wall Street analysts shows a consensus price target of $172.85, with estimates ranging from $159 (bear case) to $202 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $182, with bear/bull scenarios of $61/$189.
What is BDX's fair value based on fundamentals?
Our quantitative valuation model calculates BDX's fair value at $182 (base case), with a bear case of $61 and bull case of $189. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 56/100.
What is BDX's forward P/E ratio?
BDX trades at a forward P/E ratio of 11.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 24.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy BDX stock?
Wall Street analysts are optimistic on BDX, with a "Buy" consensus rating and $172.85 price target (19.4% upside). 16 of 33 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do BDX price targets vary so much?
BDX analyst price targets range from $159 to $202, a 25% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $172.85 consensus represents the middle ground. Our model's $61-$189 range provides an independent fundamental perspective.